Invesaro

Stocks CAC Financial statements

Financial statements

CAMDEN NATIONAL CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CAMDEN NATIONAL CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue26.828.327.73233.333.635.741.7
Interest expense16.620.83140.920.91125.194
Pre-tax income57.562.465.871.674.486.67753.865.578.7
Income tax17.533.912.714.414.917.615.610.512.513.5
Net income40.128.553.157.259.56961.443.45365.2
EPS, basic2.591.833.403.703.964.624.182.983.633.86
EPS, diluted2.571.823.393.693.954.604.172.973.623.84
Shares, basic (weighted)15.415.515.615.41514.914.614.614.616.9
Shares, diluted (weighted)15.515.615.615.5151514.714.614.617
Dividend per share0.830.941.151.231.321.481.621.681.681.68

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents87.71036775.614622175.499.821597.5
Property, plant and equipment42.941.942.541.839.937.8363537.151.3
Lease right-of-use assets1313.612.712.311.510.315.6
Goodwill94.794.794.794.794.794.794.794.794.7152
Intangible assets6.764.964.233.532.842.191.560.970.4242.6
Total assets3,8644,0654,2974,4304,8995,5005,6725,7155,8056,975
Short-term debt530542271269162212265486501582
Total liabilities3,4733,6623,8623,9564,3694,9595,2215,2195,2746,278
Total debt10.810.811.610250.07
Retained earnings249267302341378424462481509545
Other comprehensive income-13.9-20.2-24.4-6.2720.7-6.23-126-102-94.6-64.4
Shareholders' equity392403436473529541451495531697
Total equity392403436473529541451495531697
Total liabilities and equity3,8644,0654,2974,4304,8995,5005,6725,7155,8056,975
Shares outstanding15.515.515.615.114.914.714.614.614.616.9

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income40.128.553.157.259.56961.443.45365.2
Depreciation and amortization-5.05-2.833.773.893.833.713.493.373.315.21
Stock-based compensation21.471.691.891.792.382.552.792.93.42
Deferred income tax-1.3118.1-2.61.26-1.76-0.641.791.310.30.62
Cash from operations57.458.364.332.918.214310567.560.963.9
Capital expenditures-1.67-2.84-5.02-4.27-2.93-1.85-2.18-2.62-5.58-5.71
Purchases of investments-171-232-339-433-759-95.4-116-60.4-235
Sales and maturities of investments20.456.2207032217473.389.2109
Cash from investing-168-212-277-55.8-294-649-488-7.0330.3-56.4
Stock issued1.30.10.220.10.030.160.07
Share buybacks00-0.03-20.8-9.69-10.1-10.2-2-1.610
Dividends paid-12.4-14.3-17.2-18.6-19.8-21.1-23.5-24.5-24.6-28.5
Cash from financing11916917631.6346581237-36.123.9-125
Net change in cash8.2215.3-368.6470.174.9-14524.4115-117
Free cash flow55.755.559.328.615.314110364.955.458.2
Interest paid16.720.830.241.421.511.224.592.4117117
Income taxes paid10.616.810.713.515.718.513.211.18.826.15

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $57.82 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Pre-tax margin262.0%Pre-tax income / revenue.
Net margin207.1%Net income / revenue.
FCF margin239.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin252.4%Cash from operations / revenue.
Effective tax rate20.9%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)12.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.3%Net income / average total assets.
Stock-based pay / revenue8.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue12.8%Capital expenditures / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y17.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y7.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y8.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y22.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y2.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y1.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y6.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-2.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-0.6%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y4.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-15.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y28.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y5.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-17.3%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y30.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y1.2%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y4.9%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y31.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y15.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y5.6%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y20.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y7.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y7.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y16.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y4.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y2.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Liabilities / assets89.6%Total liabilities / total assets.
Goodwill and intangibles / assets2.2%(Goodwill + intangible assets) / total assets.
Tangible book value$574.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.01xRevenue / average total assets.
Fixed asset turnover0.83xRevenue / average property, plant and equipment.
FCF conversion115.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow5.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$5.21Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$2.52Revenue / diluted weighted shares.
FCF per share$6.03Free cash flow / diluted weighted shares.
Operating cash flow per share$6.35Cash from operations / diluted weighted shares.
Book value per share$42.96Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$34.00Tangible book value / shares outstanding.
Cash per share$5.91(Cash + short-term investments) / shares outstanding.
Buybacks / FCF3.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$977.0MShare price x shares outstanding.
Enterprise value$877.1MMarket cap + total debt - cash - short-term investments.
P/E11.0xMarket cap / net income. Only when net income is positive.
P/S22.8xMarket cap / revenue.
P/B1.35xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.70xMarket cap / tangible book value, when positive.
P/FCF9.53xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF9.05xMarket cap / cash from operations, when positive.
EV/Sales20.5xEnterprise value / revenue.
EV/FCF8.56xEnterprise value / free cash flow, when both are positive.
FCF yield10.5%Free cash flow / market cap.
Earnings yield9.1%Net income / market cap (the inverse of P/E).
Shareholder yield0.4%(Dividends paid + share buybacks) / market cap.
What was CAMDEN NATIONAL CORP's revenue in fiscal 2025?

CAMDEN NATIONAL CORP reported revenue of $41.7M for fiscal 2025, 17% higher than the year before.

Was CAMDEN NATIONAL CORP profitable in fiscal 2025?

Yes. Net income was $65.2M, a net margin of 156.1%.

How much free cash flow did CAMDEN NATIONAL CORP generate in fiscal 2025?

Cash from operations of $63.9M minus capital expenditures of $5.7M left free cash flow of $58.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CAMDEN NATIONAL CORP